Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-21-Speech-2-548"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-21"^^xsd:date2
dcterms:Is Part Of	lp_eu:Placing on the market and use of biocidal products (debate)2
dcterms:Language	"cs"^^xsd:language2
lpv:document identification number	"en.20100921.19.2-548"2
lpv:hasSubsequent	lp_eu:2010-09-21-Speech-2-5492
lpv:speaker	lp:Pavel Poc2
lpv:spokenAs	member; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 substitute; Delegation for relations with Iran (2009-09-16--2014-06-30)3 unknown; Česká strana sociálně demokratická (2009-07-14--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 substitute; TRAN (2009-07-16--2012-01-18)3 member; ENVI (2009-07-16--2012-01-18)3
lpv:translated text	"We have to realise that biocidal medicines, while their use may be unavoidable, are simply poisons that we come into contact with on a daily basis. As such, they simply represent a risk to human health and a burden on the environment. It is therefore logically necessary to adhere to the highest levels of protection for human health, for animals and for nature. Excessive flexibility represents a considerable risk, because the risk is not only in these materials, but also in the ways of using them, and misuse as regards the quantities in which they enter the food chain. I would consider it a major success to have a complete ban on extremely hazardous biocidal medicines, including mutagenic and carcinogenic substances and substances that are toxic from the perspective of reproduction. The new legislation is and should be ambitious and, in my opinion, the ECHA is quite capable of commencing with the unified European licensing of biocidal medicines by 2015 rather than waiting until 2017."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph